Navigation Links
Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
Date:6/19/2013

Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "should", "would", "project", "plan", "predict", "intend" and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing governmental regulation, our ability to commercialize, manufacture and achieve market acceptance of any of our product candidates, for which we rely heavily on collaboration with third parties, and our ability to protect and enforce our intellectual property rights and to operate without infringing upon the proprietary rights of third parties. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements and no assurance can be given that the actual
'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
4. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
5. Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
6. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
7. Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid and Sustainable Disease Control Irrespective of Age or High Risk Prognostic Factor
8. Ibrutinib Expanded Access Program Open to Eligible U.S. Patients with Relapsed or Refractory Mantle Cell Lymphoma
9. Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
10. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
11. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Calif. , Aug. 28, 2015  CytomX Therapeutics, ... treatment of cancer, today announced the filing of a ... and Exchange Commission (SEC) relating to a proposed initial ... shares to be offered and the price range for ... to list its common stock under the symbol "CTMX" ...
(Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Tobramycin Market, 2010-2019" ... a traditional antibiotic whose eye drop and ointment are ... potential infection or inflammation caused by eye infection. Currently, ... are able to produce tobramycin, among which the Top ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Developed by ... selective prostaglandin receptor agonist which effectively reduces intraocular ... by FDA, latanoprost (under the trade name of ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Tobramycin Market, 2015-2019 2China Latanoprost Market Investigation Report 2015-2019 2
... The healthcare and computing industries rely heavily on mobility. ... adopting new technologies allowing medical professionals and patients to ... these requirements of the industry. One new innovation is ... medical devices for communication and data transfer. ...
... N.M., May 23, 2011 Exagen Diagnostics, Inc. ... markets proprietary tests, and Medco Research Institute , ... Solutions, Inc. (NYSE: MHS ) -- ... called NIMBLE [Novel Interventions in Methotrexate Boosts Levels of ...
Cached Medicine Technology:Your Wireless Healthcare Provided By PulseOximetersPlus 2Exagen Diagnostics Inc. Partners with Medco Research Institute® to Develop NIMBLE Personalized Medicine Program for Rheumatoid Arthritis Patients 2Exagen Diagnostics Inc. Partners with Medco Research Institute® to Develop NIMBLE Personalized Medicine Program for Rheumatoid Arthritis Patients 3Exagen Diagnostics Inc. Partners with Medco Research Institute® to Develop NIMBLE Personalized Medicine Program for Rheumatoid Arthritis Patients 4
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College President ... the college’s Vice President of Strategic Initiatives and Information Services. O’Shea, who has served ... college expand its reach and impact through innovative technologies and strategies. , “I am ...
(Date:8/29/2015)... ... August 29, 2015 , ... It can be ... against dribbled urine and sweat. "In order to prevent these problems, I conceived ... ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal support for a male’s crotch. It ...
(Date:8/29/2015)... CA (PRWEB) , ... August 29, 2015 , ... ProDrop ... X . Each preset contains 15 seconds of unique footage that users can shrink ... rise, fall, zoom, attract and more. Users can customize color, brightness, scale, speed, range, ...
(Date:8/28/2015)... , ... August 29, 2015 , ... Rio Salado ... learning and the student experience as part of the EDUCAUSE - Next Generation Learning ... . , This is the third Breakthrough Models Incubator hosted by EDUCAUSE ...
(Date:8/28/2015)... ... August 28, 2015 , ... An article published August ... Paul LaRocco has gone through to open a pizzeria in Westchester. Mr. LaRocco was ... to take several months, but the current process, having already gone on for over ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2
... First-Ever Conversation between ... Tony Blair and Governor Arnold Schwarzenegger to ... WE Care, a Partnership Between The Women,s Conference,CARE International and Meredith Corporation To ... ...
... October 23 Answers.com(TM) (NASDAQ:,ANSW) today ... health education,videos from HealthiNation, a leading ... content on Answers.com. (See example at, ... consumers in categories such as business,health, ...
... critical access control features and ... support for bandwidth-intensive applications, WALTHAM, Mass. and SEATTLE, ... the leading global provider of,intelligent wireless LANs (WLANs) for ... Chiropractic, the largest,chiropractic college in the world, has selected ...
... 22, 2007 Late breaking results from the SPIRIT ... symposium of the Cardiovascular Research Foundation, show that after ... events (MACE) such as heart attacks, deaths from cardiac ... the original vessel blockage after using a Xience V ...
... Baylor College of Medicine boosted its sequencing capabilities with ... FLX Systems from 454 Life Sciences, a Roche company. ... Genome Sequencing Center will be in a unique position ... from the deciphering of new genomes to the analysis ...
... Bulletin Board: IMYN) has announced the appointment of,Stephen D. ... member. "I am honored to step into this ... I believe we have the potential to improve the,quality ... painful and,debilitating diseases," says Ferrone. Ferrone is a ...
Cached Medicine News:Health News:14,000 Women Join California First Lady Maria Shriver for The Women's Conference 2007 2Health News:14,000 Women Join California First Lady Maria Shriver for The Women's Conference 2007 3Health News:14,000 Women Join California First Lady Maria Shriver for The Women's Conference 2007 4Health News:14,000 Women Join California First Lady Maria Shriver for The Women's Conference 2007 5Health News:14,000 Women Join California First Lady Maria Shriver for The Women's Conference 2007 6Health News:Answers.com Adds HealthiNation Video Content to Answer Engine(TM) 2Health News:Palmer College of Chiropractic Selects Colubris Networks to Provide Wireless Infrastructure at Three U.S. Campuses 2Health News:Palmer College of Chiropractic Selects Colubris Networks to Provide Wireless Infrastructure at Three U.S. Campuses 3Health News:Fewer adverse cardiac events at one year 2Health News:Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments 2Health News:Immunosyn Corporation Names Stephen Ferrone as CEO 2
... IEC CL40 and FL40 Centrifuge Series ... and versatility to increase your productivity ... broad array of rotors and accessories ... microplate applications, the IEC CL40 and ...
... CL31 Multispeed Series offers unsurpassed versatility ... compact, 1.2 liter benchtop centrifuge. With ... accessories and high-speed centrifugation capabilities, the ... you need to meet a variety ...
... IEC CL30 Series from Thermo ... value for your low-speed clinical ... rotor exchange system, user-friendly controls, ... IEC CL30 Series delivers solid ...
... Freedom Blood Glucose Monitoring System has the ... it's really easy to see and hold. ... taking the smallest sample of blood. And ... of 5 seconds. With 4 programmable alarms, ...
Medicine Products: